Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Baumann

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Psychopharmacology|July 1, 2005
Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical responseGeorg Nikisch, Aleksander A Mathé, Adelheid Czernik, et al.
Therapeutic Drug Monitoring|March 21, 2023
Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical PerspectiveMaike Scherf-Clavel, Pierre Baumann, Xenia M Hart, et al.
Journal of Clinical Psychopharmacology|May 1, 2004
Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical responseGeorg Nikisch, Aleksander A Mathé, Adelheid Czernik, et al.
European Journal of Clinical Pharmacology|January 20, 2005
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patientsJacques Fellay, Catia Marzolini, Laurent Decosterd, et al.
Pharmacogenetics|April 15, 2004
CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter geneChin B Eap, Jacques Fellay, Thierry Buclin, et al.
Journal of Clinical Psychopharmacology|September 4, 2010
Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSFGeorg Nikisch, Pierre Baumann, Georg Wiedemann, et al.
The Psychiatric Quarterly|November 22, 2011
Cognitive efficacy of quetiapine in early-onset first-episode psychosis: a 12-week open label trialSébastien Urben, Pierre Baumann, Sandra Barcellona, et al.
British Journal of Clinical Pharmacology|August 16, 2003
Identification of a novel splice-site mutation in the CYP1A2 geneDelphine Allorge, Dany Chevalier, Jean-Marc Lo-Guidice, et al.
Clinical Pharmacology and Therapeutics|July 2, 2004
Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadoneMessaoud Benmebarek, Corinne Devaud, Marianne Gex-Fabry, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 geneChin B Eap, Stefan Bender, E Jaquenoud Sirot, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Psychopharmacology|July 1, 2005
Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical responseGeorg Nikisch, Aleksander A Mathé, Adelheid Czernik, et al.
Therapeutic Drug Monitoring|March 21, 2023
Behind the Curtain: Therapeutic Drug Monitoring of Psychotropic Drugs from a Laboratory Analytical PerspectiveMaike Scherf-Clavel, Pierre Baumann, Xenia M Hart, et al.
Journal of Clinical Psychopharmacology|May 1, 2004
Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical responseGeorg Nikisch, Aleksander A Mathé, Adelheid Czernik, et al.
European Journal of Clinical Pharmacology|January 20, 2005
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patientsJacques Fellay, Catia Marzolini, Laurent Decosterd, et al.
Pharmacogenetics|April 15, 2004
CYP3A activity measured by the midazolam test is not related to 3435 C >T polymorphism in the multiple drug resistance transporter geneChin B Eap, Jacques Fellay, Thierry Buclin, et al.
Journal of Clinical Psychopharmacology|September 4, 2010
Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSFGeorg Nikisch, Pierre Baumann, Georg Wiedemann, et al.
The Psychiatric Quarterly|November 22, 2011
Cognitive efficacy of quetiapine in early-onset first-episode psychosis: a 12-week open label trialSébastien Urben, Pierre Baumann, Sandra Barcellona, et al.
British Journal of Clinical Pharmacology|August 16, 2003
Identification of a novel splice-site mutation in the CYP1A2 geneDelphine Allorge, Dany Chevalier, Jean-Marc Lo-Guidice, et al.
Clinical Pharmacology and Therapeutics|July 2, 2004
Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadoneMessaoud Benmebarek, Corinne Devaud, Marianne Gex-Fabry, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 geneChin B Eap, Stefan Bender, E Jaquenoud Sirot, et al.
Pageof 10